HIV infection and obesity: Where did all the wasting go?

Antiviral Therapy

Volumn 17, Issue 7, 2012, Pages 1281-1289

  Tate, Tyler ^a   Willig, Amanda L ^b   Willig, James H ^b   Raper, James L ^b   Moneyham, Linda ^c   Kempf, Mirjam Colette ^c   Saag, Michael S ^b   Mugavero, Michael J ^b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; SIDE EFFECT; UNITED STATES; WEIGHT CHANGE; WEIGHT GAIN;

ADULT; BODY MASS INDEX; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW-UP STUDIES; HIV; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PREVALENCE; RISK FACTORS; RNA, VIRAL; TIME FACTORS;

EID: 84870512485     PISSN: 13596535     EISSN: 20402058     Source Type: Journal    
DOI: 10.3851/IMP2348     Document Type: Article

References (38)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303:235-241.
2. Sullivan PW, Morrato EH, Ghushchyan V, Wyatt HR, Hill JO. Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the US, 2000-2002. Diabetes Care 2005; 28:1599-1603. (Pubitemid 40923071)
3. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348:1625-1638. (Pubitemid 36459468)
4. Bogers RP, Bemelmans WJ, Hoogenveen RT, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med 2007; 167:1720-1728. (Pubitemid 47403058)
5. Palella FJ, Jr., Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338:853-860. (Pubitemid 28135961)
6. Smit E, Skolasky RL, Dobs AS, et al. Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999. Am J Epidemiol 2002; 156:211-218. (Pubitemid 34810474)
7. Mocroft A, Sabin CA, Youle M, et al. Changes in AIDS-defining illnesses in a London Clinic, 1987-1998. J Acquir Immune Defic Syndr 1999; 21:401-407. (Pubitemid 29384002)
8. Vance DE, Mugavero M, Willig J, Raper JL, Saag MS. Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life. J Assoc Nurses AIDS Care 2011; 22:17-25.
9. Lo J, Abbara S, Shturman L, et al. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS 2010; 24:243-253.
10. Friis-Møller N, Reiss P, Sabin CA, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356:1723-1735. (Pubitemid 46658704)
11. Brown TT, McComsey GA, King MS, Qaqish RB, Bernstein BM, da Silva BA. Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen. J Acquir Immune Defic Syndr 2009; 51:554-561.
12. Mocroft A, Reiss P, Gasiorowski J, et al. Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. J Acquir Immune Defic Syndr 2010; 55:262-270.
13. Masiá M, Padilla S, Garcia N, et al. Endothelial function is impaired in HIV-infected patients with lipodystrophy. Antivir Ther 2010; 15:101-110.
14. Willig JH, Abroms S, Westfall AO, et al. Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy. AIDS 2008; 22:1951-1960.
15. Deputy NP, Boehmer U. Determinants of body weight among men of different sexual orientation. Prev Med 2010; 51:129-131.
16. Campa A, Yang Z, Lai S, et al. HIV-related wasting in HIV-infected drug users in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 41:1179-1185. (Pubitemid 41429483)
17. Tang AM, Forrester JE, Spiegelman D, et al. Heavy injection drug use is associated with lower percent body fat in a multi-ethnic cohort of HIV-positive and HIV-negative drug users from three US cities. Am J Drug Alcohol Abuse 2010; 36:78-86.
18. Lykouras L, Michopoulos J. Anxiety disorders and obesity. Psychiatrike 2011; 22:307-313.
19. Scott D, Happell B. The high prevalence of poor physical health and unhealthy lifestyle behaviours in individuals with severe mental illness. Issues Ment Health Nurs 2011; 32:589-597.
20. Zhao G, Ford ES, Li C, Tsai J, Dhingra S, Balluz LS. Waist circumference, abdominal obesity, and depression among overweight and obese US adults: National Health and Nutrition Examination Survey 2005-2006. BMC Psychiatry 2011; 11:130.
21. NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults (US). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Bethesda, MD: National Institutes of Health 1998.
22. Amorosa V, Synnestvedt M, Gross R, et al. A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr 2005; 39:557-561. (Pubitemid 41098470)
23. Crum-Cianflone N, Tejidor R, Medina S, Barahona I, Ganesan A. Obesity among patients with HIV: the latest epidemic. AIDS Patient Care STDS 2008; 22:925-930.
24. Boodram B, Plankey MW, Cox C, et al. Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study. AIDS Patient Care STDS 2009; 23:1009-1016.
25. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005; 293:1861-1867. (Pubitemid 40548182)
26. Nguyen NT, Nguyen XM, Wooldridge JB, Slone JA, Lane JS. Association of obesity with risk of coronary heart disease: findings from the National Health and Nutrition Examination Survey, 1999-2006. Surg Obes Relat Dis 2010; 6:465-469.
27. Zannou DM, Denoeud L, Lacombe K, et al. Incidence of lipodystrophy and metabolic disorders in patients starting non-nucleoside reverse transcriptase inhibitors in Benin. Antivir Ther 2009; 14:371-380.
28. Polsky S, Floris-Moore M, Schoenbaum EE, Klein RS, Arnsten JH, Howard AA. Incident hyperglycaemia among older adults with or at-risk for HIV infection. Antivir Ther 2011; 16:181-188.
29. Jones CY, Hogan JW, Snyder B, et al. Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis 2003; 37 Suppl 2:S69-S80. (Pubitemid 37102727)
30. Centers for Disease Control and Prevention. Behavioral risk factor surveillance system prevalence and trends. Department of Health and Human Services (Updated 2010. Accessed 17 February 2012.) Available from http://apps.nccd.cdc.gov/brfss/display-c.asp?yr-c=2000&yr=2008&cat= OB&state=AL&bkey=20080127&qkey=4409&qtype=C&grp= 0&SUBMIT2=Compare
31. Shor-Posner G, Campa A, Zhang G, et al. When obesity is desirable: a longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort. J Acquir Immune Defic Syndr 2000; 23:81-88. (Pubitemid 30123269)
32. Malvy E, Thiebaut R, Marimoutou C, Dabis F. Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine Cohort, France, 1985-1997. J Am Coll Nutr 2001; 20:609-615. (Pubitemid 34008058)
33. Palenicek JP, Graham NM, He YD, et al. Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10:366-373.
34. Silva M, Skolnik PR, Gorbach SL, et al. The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 1998; 12:1645-1651. (Pubitemid 28418335)
35. Centers for Disease Control and Prevention. Adult obesity facts. Department of Health and Human Services (Updated August 2012. Accessed 9 October 2012.) Available from http://www.cdc.gov/obesity/data/adult.html
36. Centers for Disease Control and Prevention. HIV/AIDS surveillance report, volume 16. Department of Health and Human Services. (Updated 5 April 2011. Accessed 17 February 2012.) Available from http://www.cdc.gov/hiv/surveillance/ resources/reports/2010supp-vol16no1/index.htm#5
37. Romero-Corral A, Somers VK, Sierra-Johnson J, et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond) 2008; 32:959-966. (Pubitemid 351986216)
38. Rahman M, Berenson AB. Accuracy of current body mass index obesity classification for white, black, and Hispanic reproductive-age women. Obstet Gynecol 2010; 115:982-988.